Actor
EVIR Therapeutics
Development, manufacture, production and marketing of modified dendritic cell vaccines for cancer immunotherapy.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.09 Proteins & Peptides
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Immunology & Allergy, Oncology
Main sector
Biotech
Contact
Bât EPFL Innovation Park F c/o NanoDimension S.A
1015 Lausanne / VD
+41 21 561 33 00